Sanofi, Cambridge, MA, USA, United States
Disclosure information not submitted.
5F-05 - Effectiveness of Sarilumab vs. Methotrexate as a Glucocorticoid-sparing agent in Patients with Polymyalgia Rheumatica
Tuesday, August 26, 20259:30 AM - 9:45 AM ET
